Modificaciones de los lípidos séricos, el fibrinógeno y otros parámetros hemostáticos por acción del ciprofibrato, en pacientes hiperlipidémicos con y sin enfermedad arterial coronaria

Espinosa, Raúl; Rodríguez Roa, Elsy; Nagy, Elena; Mijares, Mercedes; Rodríguez, Larralde, Alvaro; Gil, Amparo; Lundberg, Ulf; Carvajal, Zoila; Castillo, Luis; Arocha Piñango, Carmen.
Invest. clín ; 47(1): 35-48, mar. 2006. tab, graf
Artículo en Español | LILACS | ID: lil-449268

Documentos relacionados

  1. Prediction of injury localization in preoperative patients with gastrointestinal perforation: a multiomics model analysis.
  2. There May Not Be a Definite Winner, But Fibrinogen Concentrate is Clearly a Factor to Be Reckoned With.
  3. Fifty Years of Fibrinogen Structure and Function.
  4. In response: Overestimation of fibrinogen concentration in cryoprecipitate by repeated freeze-thawing with long thawing period as used in the Clauss method.
  5. Lithium-Modified Sorbent: Effects on Hemostatic Responses In Vitro.
  6. Effect of fibrinogen replacement therapy on bleeding outcomes and 1-year mortality in patients undergoing thoracic aortic surgery: a retrospective cohort study.
  7. Changing hemostatic management in post-partum hemorrhage.
  8. Overestimation of fibrinogen concentration in cryoprecipitate by repeated freeze-thawing with long thawing period as used in the Clauss method.
  9. Self-Assembled Fibrinogen Hydro- and Aerogels with Fibrin-like 3D Structures.
  10. The Molecular Structure of Fibrinogen.